Literature DB >> 32295570

The social determinants of otitis media in aboriginal children in Australia: are we addressing the primary causes? A systematic content review.

Jack DeLacy1, Tinashe Dune2,3, John J Macdonald4,5.   

Abstract

BACKGROUND: Aboriginal and Torres Strait Islander children experience some of the highest rates of otitis media in the world. Key risk factors for otitis media in Aboriginal children in Australia are largely social and environmental factors such as overcrowded housing, poverty and limited access to services. Despite this, little is known about how to address these risk factors. A scoping content review was performed to determine the relationship between social determinants of health and otitis media in Aboriginal and Torres Strait Islander children as described by peer-reviewed and grey literature.
METHOD: Search terms were established for location, population and health condition. The search terms were used to conduct a literature search using six health research databases. Following the exclusion process, articles were scoped, analysed and categorised using scoping parameters and a social determinants of health framework.
RESULTS: Housing-related issues were the most frequently reported determinants for otitis media (56%). Two articles (4%) directly investigated the impact of social determinants of health on rates of otitis media within Aboriginal and Torres Strait Islander children. The majority of the literature (68%) highlights social determinants as playing a key role in the high rates of otitis media seen in Aboriginal populations in Australia. There were no intervention studies targeting social determinants as a means to reduce otitis media rates among Aboriginal and Torres Strait Islander children.
CONCLUSIONS: This review identifies a disconnect between otitis media drivers and the focus of public health interventions within Aboriginal and Torres Strait Islander populations. Despite consensus that social determinants play a key role in the high rates of otitis media in Aboriginal and Torres Strait Islander children, the majority of intervention studies within the literature are focussed on biomedical approaches such as research on vaccines and antibiotics. This review highlights the need for otitis media intervention studies to shift away from a purely biomedical model and toward investigating the underlying social determinants of health. By shifting interventions upstream, otitis media rates may decrease within Aboriginal and Torres Strait Islander children, as focus is shifted away from a treatment-focussed model and toward a more preventative model.

Entities:  

Keywords:  Aboriginal; Aboriginal and Torres Strait islander; Australia; Children; Ear disease; Hearing; Indigenous; Otitis media; Social determinants of health

Year:  2020        PMID: 32295570     DOI: 10.1186/s12889-020-08570-3

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  3 in total

1.  Ear microbiota and middle ear disease: a longitudinal pilot study of Aboriginal children in a remote south Australian setting.

Authors:  Patricia MacFarlane; Geraint B Rogers; Steven L Taylor; Lito E Papanicolas; Alyson Richards; Furdosa Ababor; Wan Xian Kang; Jocelyn M Choo; Charmaine Woods; Steve L Wesselingh; Eng H Ooi
Journal:  BMC Microbiol       Date:  2022-01-13       Impact factor: 3.605

2.  Feasibility, accessibility and acceptability a pharmacist-led ear health intervention at rural community pharmacies (LISTEN UP): a mixed-methods study in Queensland, Australia.

Authors:  Selina Taylor; Alice Cairns; Beverley Dawn Glass
Journal:  BMJ Open       Date:  2022-04-01       Impact factor: 2.692

3.  Acute Otitis Media in Children-Challenges of Antibiotic Resistance in the Post-Vaccination Era.

Authors:  Cristina Gavrilovici; Elena-Lia Spoială; Ingrith-Crenguţa Miron; Iuliana Magdalena Stârcea; Codruţa Olimpiada Iliescu Haliţchi; Irina Nicoleta Zetu; Vasile Valeriu Lupu; Carmen Pânzaru
Journal:  Microorganisms       Date:  2022-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.